We've received some enquiries and concerns about the supply of hydroxychloroquine again following US President Donald Trump's remarks yesterday. Therefore we have updated our article at lupusuk.org.uk/covid19-hydr...
On Tuesday 19th May 2020, US President Donald Trump alleged that he is currently taking hydroxychloroquine as a preventative measure against COVID-19. This is despite any evidence indicating that the medication may have a protective effect against the virus and warnings that it could be unsafe for treating COVID-19.
In March 2020 following a previous press conference in which President Trump praised hydroxychloroquine as a potential “game changer” in the fight against COVID-19, global demand for the drug increased significantly; this even caused a short-term supply issue in some parts of the UK.
We do not anticipate any supply issues in the UK following this latest announcement. Following the previous shortage, due to an unexpected increase in demand, action has been taken by regulators and government to safeguard stocks for people with lupus and other autoimmune rheumatic conditions and prevent prescriptions being written for people concerned about COVID-19.